Showing 241-250 of 345 grants

Title Institution Researcher Program Duration Total Award Amount
Non-invasive immunoimaging of islet transplant rejection Beckman Research Institute of the City of Hope Fouad Kandeel Cures 01-June-2023 to 31-May-2026 $750.000,00
Determining how NKG2D signaling drives autoimmune diabetes University of Kansas Medical Center Research Institute, Inc. Mary Markiewicz Cures 01-September-2023 to 31-August-2026 $750.000,00
mIL-2/CD25 fusion protein and BTK inhibitor combination therapy for T1D University of Miami Wasif Khan Cures 01-May-2023 to 30-April-2026 $974.996,00
Newly identified novel autoantibodies specific to β-cell surface ZnT8 antigen as an early biomarker in type 1 diabetes Regents of the University of Colorado Xiaofan Jia Cures 01-September-2023 to 28-February-2026 $499.998,96
Defining human T cell-myeloid cell interactions in the islets Regents of the University of Colorado Rachel Friedman Cures 01-March-2023 to 28-February-2026 $110.000,00
Validation of a Tolerogenic Nanotherapy for Islet Transplantation in a Non-Human Primate Model Northwestern University Jacqueline Burke Cures 01-July-2023 to 30-June-2026 $998.275,64
Defining the Antigenic Landscape of Islet-Infiltrating T cells in Type 1 Diabetes University of Pittsburgh Alok Joglekar Cures 01-March-2023 to 28-February-2026 $900.000,00
Cellular Sentinels of Islet Transplant Rejection California Institute of Technology Mikhail Shapiro Cures 01-July-2023 to 30-June-2026 $750.000,00
Multiplex in vivo imaging of the dynamics of immune-mediated rejection of allogenic islet grafts The Regents of the University of California, Los Angeles Oluwatayo Ikotun Cures 01-February-2024 to 31-January-2027 $749.996,25
Targeting Prostaglandin F-series Lipids to Counter Beta-Cell-Death and T1D Development The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham Sasanka Ramanadham Cures 01-May-2023 to 30-April-2026 $749.763,00